Real Endpoints brings a wide range of strategic and operational market access solutions to our clients.
News and Events
Panelists: Jeffrey Berkowitz, Real Endpoints
Roger Longman, Real Endpoints
Dennis Purcell, Aisling Capital
The pharmaceutical landscape is littered with the market-access failures of recent biotech launches – the reason investors now often “sell on the launch” -- innovative science and a biotechs’ vision of “unmet medical need” are often irrelevant or meaningless to payers. Even the earliest target product profile needs to reflect “unmet need” from the payer’s point of view – using an objective, broad and forward-looking understanding of competition -- and create a medical and economic roadmap for minimizing payer restrictions.
December 14, 2018
12:45 PM EST
Real Endpoints, which provides development and implementation of proprietary tools, has named Jeff Berkowitz as CEO and member of the board of directors. Most recently, Mr. Berkowitz served as an executive VP at UnitedHealth Group, CEO of it Optum International business, and as a strategic leader of OptumRx, its PBM, Mr. Berkowitz is a PharmaVOICE Red Jacket - 2014.
October 16, 2018
PharmaVoiceRead full article >
Attendee: Real Endpoints team
The Academy of Managed Care Pharmacy (AMCP) is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government.
October 22, 2018
October 25, 2018
Orlando, FLevent >
by Richard Mark Kirkner
The first gene therapy to treat an inherited disease is out of the gate, but with a very high price tag. Many more gene therapies are on their way. How can they be priced to hit the sweet spot of affordability, access, and innovation?
July 25, 2018
Managed Careread full article >
Recent Insightsview archive >
November 18, 2018
Amid national angst over prescription drug pricing, Express Scripts is touting a new scheme it says will lessen the behind-the-scenes role that rebates play in rising costs. In effect, Express Scripts would create a two-tier system for its customers which could choose between a formulary with a high list price and high rebate, or the newer plan that will offer a lower list price and lower or no rebate.read full insight article >
November 5, 2018
Jeff Berkowitz, CEO, Real Endpoints' is quoted, "It becomes a global index that reflects the value as seen by number of different entities against all of the other choices they need to make from a health delivery perspective."read full insight article >
National Business Director
Top 5 Pharma
Specialty Access Solutions, Top 5 Pharma
Director of Operations
Reimbursement and Patient Support Services, Top 20 Pharma
Chronis H. Manolis, RPh
Vice President, Pharmacy UPMC Health Plan
President , GlaxoSmithKline U.S.